Sarepta Therapeutics

ISIN US8036071004

WKN A1J1BH

Marktkapitalisatie (in EUR)

2,111 m

Land

United States

Sector

Healthcare

Dividendrendement

0.00%

|One app for all your investments. Buy crypto, stocks and ETFs easily with Bitpanda. Learn more

Overzicht

Koers

Beschrijving

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Toon meer Toon minder

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Grafiek

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR	2,111 m
WPA, EUR	-7.48
KBV	2.1
K/W	27.2
Dividendrendement	0.00%

Winst- en verliesrekening (2025)

Omzet, EUR	1,949 m
Netto-inkomen, EUR	-632 m
Winstmarge	-32.45%

In welke ETF zit Sarepta Therapeutics?

Er zijn 5 ETF's die Sarepta Therapeutics bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van Sarepta Therapeutics is de iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weging	Investeringsfocus	Fondsgrootte (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.14%	Aandelen Verenigde Staten Gezondheidszorg Biotech	48
iShares S&P SmallCap 600 UCITS ETF	0.12%	Aandelen Verenigde Staten Small Cap	2.284
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	Aandelen Wereld Sociaal/Milieu	465
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.00%	Aandelen Noord-Amerika Sociaal/Milieu	23
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.03%	Aandelen Verenigde Staten Small Cap	189

Prestaties

Rendementsoverzicht

YTD	+8,24%
1 maand	+44,19%
3 maanden	+10,56%
6 maanden	+5,24%
1 jaar	-62,53%
3 jaar	-84,15%
5 jaar	-
Since inception	-66,31%
2025	-83,97%
2024	+30,92%
2023	-25,66%
2022	+48,54%

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).